We are live on ! Find out more
EBACW

European Biotech Acquisition Corp. Warrant
EBACW

Delisted

EBACW was delisted on the 2nd of March, 2023.

Back to rankings

30 hedge funds and large institutions have $1.61M invested in European Biotech Acquisition Corp. Warrant in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

15% more funds holding

Funds holding: 26 → 30 (+4)

8% less capital invested

Capital invested by funds: $1.75M → $1.61M (-$133K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
30
Holders Change
+4
Holders Change %
+15.38%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
–
Reduced
1
Closed
3
Calls
$1.06M
Puts
–
Net Calls
+$1.06M
Net Calls Change
-$12K

Top Buyers

Rank Fund Capital Flow
1
PC
Periscope Capital
Ontario, Canada
+$98.9K
2
AMH
Apollo Management Holdings
New York
+$21.3K
3
WA
Whitebox Advisors
Minnesota
+$10.8K
4
UBS Group
UBS Group
Switzerland
+$256

Top Sellers

Rank Fund Capital Flow
1
AC
Athanor Capital
New York
-$380K
2
LA
Linden Advisors
New York
-$16K
3
EAM
Exos Asset Management
New York
-$9K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$647K – – –
Citadel Advisors
2
Citadel Advisors
Florida
$182K – – –
AA
3
AQR Arbitrage
Connecticut
$142K – – –
PC
4
Periscope Capital
Ontario, Canada
$88K +$98.9K +154,800 New
ACA
5
Arena Capital Advisors
California
$60K – – –
SCM
6
Suvretta Capital Management
New York
$60K – – –
WP
7
Woodline Partners
California
$55K – – –
MI
8
MMCAP International
Cayman Islands
$46K – – –
SC
9
Sculptor Capital
New York
$36K – – –
FTCM
10
Fir Tree Capital Management
New York
$30K – – –
PMAM
11
Picton Mahoney Asset Management
Ontario, Canada
$26K – – –
MCM
12
Moore Capital Management
New York
$25K – – –
LA
13
Linden Advisors
New York
$22K -$16K -25,026 -38%
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
$22K – – –
CCM
15
CAAS Capital Management
New York
$20K – – –
DCM
16
Dupont Capital Management
Delaware
$20K – – –
TCM
17
Tenor Capital Management
New York
$20K – – –
AMH
18
Apollo Management Holdings
New York
$20K +$21.3K +33,260 New
GF
19
Gabelli Funds
New York
$15K – – –
GCIA
20
Gabelli & Co Investment Advisers
New York
$13K – – –
SCC
21
Spring Creek Capital
Kansas
$10K – – –
WA
22
Whitebox Advisors
Minnesota
$10K +$10.8K +16,833 New
DC
23
Dryden Capital
Florida
$9K +$9.59K +15,000 New
ACM
24
Atalaya Capital Management
New York
$8K – – –
DCM
25
Difesa Capital Management
New York
$8K +$9.05K +14,159 New
1
2

EBACW Hedge Fund Activity: Q4 2021 in Review

30 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in European Biotech Acquisition Corp. Warrant (EBACW) for Q4 2021, worth a combined $1.61M — down 7.6% from $1.75M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new EBACW positions and 3 closed out — a net gain of 4 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Periscope Capital, opening a new position worth an estimated $98.9K. The largest seller was Athanor Capital, exiting entirely with an estimated $380K sold.

  • 30 institutional investors held European Biotech Acquisition Corp. Warrant (EBACW) as of Q4 2021, up from 26 in Q3 2021.
  • Funds reported $1.61M of European Biotech Acquisition Corp. Warrant stock for Q4 2021, down 7.6% quarter-over-quarter.
  • 7 funds opened new European Biotech Acquisition Corp. Warrant positions in Q4 2021 and 3 closed out, a net change of +4 holders.
  • The largest European Biotech Acquisition Corp. Warrant buyer in Q4 2021 was Periscope Capital, an estimated $98.9K added.
  • The largest European Biotech Acquisition Corp. Warrant seller in Q4 2021 was Athanor Capital, an estimated $380K sold.

Based on aggregated 13F filings for Q4 2021.